Maze Therapeutics Inc
(MAZE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 316,773 | 264,541 | 294,374 | 196,812 | 0 |
| Marketable Securities | 67,162 | N/A | N/A | N/A | 0 |
| TOTAL | $391,302 | $271,150 | $299,707 | $201,671 | $0 |
| Non-Current Assets | |||||
| PPE Net | 5,538 | 6,006 | 6,314 | 6,668 | N/A |
| Other Non-Current Assets | 25,218 | 26,363 | 26,819 | 32,203 | 0 |
| TOTAL | $30,756 | $32,369 | $33,133 | $38,871 | $N/A |
| Total Assets | $422,058 | $303,519 | $332,840 | $240,542 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,918 | 3,666 | 2,404 | 1,939 | 0 |
| Accrued Expenses | 14,430 | 11,516 | 11,539 | 14,102 | 0 |
| TOTAL | $22,112 | $19,900 | $18,617 | $20,673 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 20,510 | 21,381 | 22,155 | 531,052 | 0 |
| TOTAL | $20,510 | $21,381 | $22,155 | $531,052 | $N/A |
| Total Liabilities | $42,622 | $41,281 | $40,772 | $551,725 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,119 | 43,851 | 43,797 | N/A | N/A |
| Common Shares | 48 | 44 | 44 | 2 | 0 |
| Retained earnings | -454,979 | -424,892 | -391,213 | -358,427 | 0 |
| Other shareholders' equity | 69 | 0 | 0 | 0 | 0 |
| TOTAL | $379,436 | $262,238 | $292,068 | $-311,183 | $0 |
| Total Liabilities And Equity | $422,058 | $303,519 | $332,840 | $240,542 | $0 |